Qilu Pharmaceutical Co., Ltd.

This is an early-stage study testing a new drug called QLS-1304 in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose, see how the body processes the drug, and check for any early signs that it might help …

This study is comparing a new drug called ESG401 to standard chemotherapy as the first treatment for advanced triple-negative breast cancer that cannot be removed by surgery. It will involve about 504 patients whose cancer has spread or come back. The main goals are to see if ESG…

This study is testing whether a new combination of antibiotics (meropenem + pralurbactam) works as well as an existing treatment (ceftazidime + avibactam) for serious pneumonia that patients get in hospitals or while on ventilators. It will involve about 420 adults with these inf…

This study is testing a new drug called QLC5508, given by IV along with other cancer medications, for people with advanced solid tumors. The main goals are to find the safest and most effective dose and to see if the treatment can shrink tumors. The trial will enroll about 444 ad…

This study is testing whether two new drugs, QLP2117 and QL2107, are safe and effective when given together to patients with advanced solid tumors that have stopped responding to standard treatments. Researchers will enroll 90 patients to find the right dose and see if the combin…

This study is testing whether a new immunotherapy drug called QL1706, given before surgery, works better than standard treatments for a specific type of colon cancer. It will involve 363 adults with a genetic feature in their tumor (MSI-H/dMMR) that makes it more likely to respon…

This study is testing a new drug called QLS32015 for people with multiple myeloma that has come back or stopped responding to other treatments. It will compare the new drug against two standard treatment combinations to see which is better at controlling the cancer and is safer. …

This study is testing a new drug called QLS1304 in combination with standard hormone therapy for people with advanced ER+/HER2- breast cancer that has stopped responding to previous hormone treatments. The trial aims to find the safest and most effective dose and see if the combi…

This study is testing whether a new drug called QLS32015 works better when combined with other existing myeloma drugs. It is for people whose multiple myeloma has come back or is no longer responding to their current treatments. The main goals are to see if the combinations can s…

This study is testing if adding a new drug called QLS31905 to standard chemotherapy works better than chemotherapy alone for adults with advanced pancreatic cancer that has a specific marker (CLDN18.2). It will involve about 602 people who have not yet received treatment for thei…

This study is testing whether a daily pill called relugolix can safely reduce heavy menstrual bleeding in women who have uterine fibroids. About 120 participants will take either the real pill or a placebo (a dummy pill) for 12 weeks to see which one works better. The main goal i…

This study is testing a new drug called QLS2309 for adults with advanced blood cancers that have returned or stopped responding to other treatments. The main goals are to find a safe dose and see how the body handles the drug. Researchers will also look for early signs that the d…

This study is testing if an investigational drug called QL0911 can safely and effectively raise platelet counts in cancer patients. Low platelets, a common and serious side effect of chemotherapy, can force treatment delays. The goal is to help patients complete their planned can…

This early-stage study aims to understand how a new antibiotic combination reaches different parts of the lungs in healthy adults. Researchers will measure drug levels in blood, lung fluid, and immune cells after intravenous administration. The study involves 16 healthy Chinese p…